Move toward accomplishing your therapy goals with the ANEUVO ExaStim® Stimulation System, a portable, non-surgical neurostimulation device designed to help help improve hand sensation and strength. ExaStim moves with you—from clinic to home—making it easier to move your goals forward.
ExaStim offers the benefits of spinal stimulation without the risks and complications of surgery.
As a non-invasive device, it provides effective transcutaneous (through the skin) spinal stimulation, without the need for device implantation. This means no downtime for recovery, and no medical procedures to upgrade or replace the device in the future.
You can feel confident that ExaStim is a safe and effective therapy option. ExaStim was shown to be safe in clinical studies, with no serious side effects caused by device use.
ANEUVO clinical studies showed patients with chronic, traumatic spinal cord injuries who received ExaStim demonstrated 2x greater functional improvement than the placebo group. Patients saw meaningful strength improvements within 8 weeks of therapy that were sustained even after therapy ended. Results showed 85% of patients experienced an improvement in dexterity of one or both hands that was sustained even 4 weeks after cessation of treatment.*
*Results from the ASPIRE study. According to performance on 9-Hole Peg Test.
Data based on analysis of Modified Intent-to-Treat (MITT), treatment as administered population.
The ExaStim Stimulation System is a non-invasive neurostimulation device that helps to improve lost hand and arm sensation and strength due to chronic spinal cord injury (SCI). It works by providing electrical stimulation to the body via a flexible electrode pad that adheres to the skin. The electrode pad is placed along the spine and can be easily removed when the therapy session is complete. This form of therapy is called transcutaneous spinal stimulation, or TSS. Transcutaneous means “applied across the skin,” and in the case of TSS, it refers to nonsurgical spinal stimulation.
Neurostimulation is a treatment that uses controlled electrical impulses to help regulate the activity of nerves and brain cells. One form of this treatment is called spinal cord stimulation, which targets the spinal cord — a central pathway that carries signals between the brain and the rest of the body. These signals help control movement, sensation, and important body functions.
When the spinal cord is injured, the communication between the brain and body can be disrupted. This can lead to paralysis, changes in sensation, difficulty with movement, and
challenges with bladder, bowel, or sexual function.
ExaStim Transcutaneous Spinal Stimulation Therapy is designed to help restore some of this lost function in a non-invasive way. It delivers precise electrical stimulation to specific nerves in the spinal cord, helping to reactivate the nerve pathways that may have been disrupted by injury. By stimulating these pathways, ExaStim may support the recovery of movement and other bodily functions.
Neurostimulation has been shown to improve motor function when combined with standard rehabilitation therapy1—but many neurostimulation devices require surgery. Devices are often implanted near the spinal cord, in order to directly activate nerves and muscles. While this method can be effective, surgery necessitates downtime, creates additional risk, and requires additional time for recovery. Implanted devices may also need to be removed or replaced over time, requiring additional surgeries.
ExaStim offers the benefits of spinal stimulation without the risks and complications of surgery. As a non-invasive neurostimulation device, it provides effective transcutaneous spinal stimulation, without the need for device implantation. This means no downtime for recovery, and no medical procedures to upgrade or replace the device in the future.
The Company
Read what clinicians and people with lived experience have to say about ANEUVO and the ExaStim Stimulation System.
“I feel slightly stronger and my range of motion might be a little bit better. Like I feel like I can reach an itch on my head a bit better. My ability to pick up small objects is sort of improved too. I can’t pinch, but tendonesis may be stronger.”
“Overall, I loved using the device. It provided me with such great feedback and input with stimulation, and I thought my hand function improved greatly!”
“My experience with the ExaStim device was extraordinary. After four weeks of use, I saw a significant increase in my ability to manipulate objects with my hands that hadn’t been present before. Just as important, in the short period of time I participated in the study I realized a marked improvement in sensation.“
“Overall, I highly recommend patients try ExaStim. It takes a little getting used to, but the results were incredible after using it for only 4 weeks. As a quadriplegic, the most life-changing result would be to regain any amount of hand/wrist function — and ANEUVO made that a reality! I look forward to using the device again in the future!”
“Having a high–level SCI, my son’s deepest desire has not been to walk but rather to have functioning hands again. In only 4 weeks, ExaStim has allowed him to hold and pour a drink into his own mouth!”
“If this brought more independence in as little as one month, it is extremely exciting to think of what it will do with prolonged use! Thank you, ANEUVO for restoring hope and some function!“
“As a neuro physical therapist specializing in spinal cord injury rehabilitation, I highly recommend the ExaStim Trans Spinal Stimulation (TSS) device by ANEUVO as a cutting-edge adjunct to activity-based therapy.”
“After only a month using this TSS for an average of 3 times a week at an hour each, the ExaStim has given me the independence to pick up a cup and drink without a straw for the first time in years!”
“It alleviated that warm-up need when doing activities. Because of the sensory aspect, I felt the motion was more fluid. I may not have been able to do more, but the movements I could do were more fluid. One of the best things about doing this at home was helping my family cook food with the stimulation on — I was able to cut up beets and put them on the slicer.”
“ANEUVO offers something unique to chronic cervical spinal sufferers. It offers hope. The device and the stimulation provided a spark that started to make certain movements possible and other movements easier. Since it’s transcutaneous, it’s non-invasive and there’s really no reason to not at least try the stim.”
U.S. market entry furthers global mission for accessible clinical and at-home non-invasive neuromodulation therapy Los Angeles, CA, April 16, 2026 (GLOBE NEWSWIRE) -- ANEUVO, a...
Read more
EASTHAMPTON, MA (WGGB/WSHM) -- Nearly a decade after a training ride crash left him with a spinal cord injury, an Easthampton man is regaining function...
Read more
Proceeds to support manufacturing growth, regulatory advancement, and disciplined commercialization expansion Los Angeles, CA, March 05, 2026 (GLOBE NEWSWIRE) -- ANEUVO, a medical technology company...
Read more
Honor highlights international startup advancing non-invasive rehabilitation technology for people living with chronic spinal cord injury Los Angeles, CA, Feb. 11, 2026 (GLOBE NEWSWIRE) --...
Read more
The first MDR-Approved Non-Invasive Spinal Stimulation System in Europe Los Angeles, CA, Sept. 16, 2025 (GLOBE NEWSWIRE) -- ANEUVO today announced its participation in two...
Read more
Key Milestone Signals Readiness for European Market Entry and Commitment to Quality Los Angeles, CA, April 09, 2025 (GLOBE NEWSWIRE) -- ANEUVO, a pioneer in...
Read more
This new phase of clinical research will test the safety and feasibility of ANEUVO’s non-invasive therapy for future use by individuals living with chronic spinal...
Read more
BOSTON — Michael Feinberg has had three years to think about the moment on the ski slope that changed his life forever. “It’s horrifying,” he...
Read more[1] Seáñez, I., Capogrosso, M. Motor improvements enabled by spinal cord stimulation combined with physical training after spinal cord injury: review of experimental evidence in animals and humans. Bioelectron Med 7, 16 (2021). https://doi.org/10.1186/s42234-021-00077-5.
